Search-intent handling Oral, injectable, reconstitution, or dosing searches are treated as compliance-sensitive topics
If pregnancy occurs while taking semaglutide, the medication should be discontinued immediately, and the healthcare provider should be notified
doi: 10.1152/ajpgi.00272.2005 50 MokhtarF
In a combined fertility and prenatal and postnatal study in male and female rats at subcutaneous doses up to 0.36 mg/kg/day, which was approximately 50 times the recommended human subcutaneous starting dose of 0.2 units/kg/day (0.007 mg/kg/day) maternal toxicity due to dose-dependent hypoglycemia, including some deaths, was observed
After (hopefully) altering the expression of candidate genes, we expect to find changes in cardiac glycosides levels, thereby identifying genes that are present in the biosynthetic pathway
Farid, Mohamad et al